Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
This trial is active, not recruiting.
|Condition||hpv vaccination status|
|Treatments||tailored educational materials, untailored educational materials, survey-only|
|Sponsor||University of Colorado, Denver|
|Collaborator||University of Michigan|
|Start date||June 2014|
|End date||December 2015|
|Trial size||1205 participants|
|Trial identifier||NCT02145156, 14-0402, PCORI 1455|
The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The objectives/aims of this HPV educational intervention project are:
1. To determine patterns of intervention utilization among parents/patients in different arms of the intervention,
2. To measure the quality of the HPV vaccine decision among parents/patients in different arms of the intervention, and
3. To determine if different arms of the intervention affect the likelihood of HPV vaccination among patients.
The implementation of this educational intervention in clinic waiting rooms is intended to assist primary care providers in communicating HPV vaccine awareness and education to parents and patients in a culturally tailored format.
|Intervention model||parallel assignment|
|Masking||single blind (subject)|
|Primary purpose||health services research|
Quality of the HPV vaccine decision among parents/patients
time frame: 18 months
Likelihood of HPV vaccination among patients
time frame: 18 months
Male or female participants from 18 years up to 75 years old.
Inclusion Criteria: 1. Parents of an adolescent between the ages of 9-17; OR a young adult patient between the ages of 18-26; 2. Adolescent/young adult has not yet received all three doses of the HPV vaccine. 3. Parent/young adult can read and converse in either English or Spanish Exclusion Criteria: 1. Age <18, 2. Prisoners 3. Decisionally challenged subjects 4. Those who cannot read and converse in either English or Spanish 5. Those who have received all 3 doses of the HPV vaccine
|Official title||Educational Intervention to Minimize Disparities in HPV Vaccination|
|Principal investigator||Amanda F Dempsey, MD, PhD, MPH|
|Description||While HPV infection is nearly ubiquitous among the sexually active population, the morbidity and mortality from HPV-related diseases disproportionately affects minorities and the poor. Hispanic women are at particularly high risk as they have the highest rates of invasive cervical cancer when compared to all other racial or ethnic groups in the U.S. Initiating the 3-dose HPV vaccination series is more common among Hispanic adolescents than whites, but series completion has been lowest among Hispanic populations. To understand barriers to HPV vaccination and to provide insight into ways in which an existing educational intervention should be modified for a Hispanic population, the investigators conducted focus groups among Hispanic parents and Latina young adults. All groups reported vaccine cost, access to insurance, and a general lack of awareness and/or understanding of either HPV or the vaccine as barriers. All groups also wanted substantially more "general" information about both HPV and the vaccine in order to make informed vaccination decisions. The educational intervention was generally well received but there were universal suggestions from all the groups to provide additional basic information about HPV infection, to add information about the vaccine for boys/young men, and to modify the color scheme and logo to make it more eye-catching and pleasing. This next phase of the project will be comprised of real world testing of an iPad-based educational intervention about HPV, "Combatting HPV Infection and Cancer" (CHICOS) that has been revised and developed per focus group feedback to target the Hispanic population. By providing information that patients and parents have clearly indicated they want in a way that is culturally sensitive and meaningful and also individually personalized, the investigators hope to improve both the HPV vaccination decision-making process and HPV vaccination rates.|
Call for more information